Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control studyResearch article Published on 2022-08-092022-10-05 Journal: The Lancet. Infectious Diseases [Category] SARS, 변종, [키워드] 95% CI Abstract adjusted odds ratio analysed Antigen association B.1.1.529 BNT162b2 booster dose Brazil case-control study collected Control Council country COVID-19 COVID-19 infection COVID-19-related symptom death dose Effectiveness excluded Fazer finding funding hospitalisation individual information Innovation material Medical Research Council National negative test Occurrence of BNT162b2 outcome peaked Positive test receiving recorded reducing remained SARS-CoV-2 SARS-CoV-2 RT-PCR SARS-CoV-2 test Scottish second dose severe COVID-19 severe disease Sex significantly lower symptom onset symptomatic symptomatic infection symptomatic SARS-CoV-2 infection Symptoms the SARS-CoV-2 translation vaccination Vaccine vaccine efficacy variant Wellcome Trust [DOI] 10.1016/S1473-3099(22)00451-0 [Article Type] Research article
Antibody responses to the SARS-CoV-2 vaccines in hemodialysis patients: Is inactivated vaccine effective?혈액투석 환자에서 SARS-CoV-2 백신에 대한 항체 반응: 불활성화 백신이 효과적인가?Article Published on 2022-08-012022-09-11 Journal: Therapeutic apheresis and dialysis : official peer [Category] MERS, SARS, 진단, 치료기술, [키워드] antibody antibody level antibody levels Antibody Response carried Comparative control group COVID-19 detected antibody dose Effectiveness General population generate healthy volunteers Hemodialysis humoral Humoral response humoral responses immunization inactivated Inactivated vaccine investigated Maintenance hemodialysis mRNA mRNA vaccine mRNA vaccines Patient patients Receptor binding domain reduced SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 vaccine SARS-CoV-2 vaccines Seropositivity significantly lower Spike protein symptomatic infection the SARS-CoV-2 Vaccine vaccine group Vaccines were measured while [DOI] 10.1111/1744-9987.13752 PMC 바로가기 [Article Type] Article
Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance유전적 거리 분석을 통한 SARS-CoV-2 변이체의 증상 감염에 대한 COVID-19 백신 효과의 신속한 평가Article Published on 2022-08-012022-09-11 Journal: Nature Medicine [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 임상, [키워드] 95% prediction interval accounted acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis analyzed applied circulating clinical trial collected Concordance coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine delta variant Effectiveness Efficacy Genetic Genetic variant highest lowest mixed-effects model mRNA vaccine observational study offer omicron pandemic platform predict predicted Predictive protective effect Protective effects Public health responses Rapid real time Receptor-binding domain regions reported SARS-CoV-2 SARS-CoV-2 sequence SARS-CoV-2 sequences SARS-CoV-2 spike protein SARS-CoV-2 variant severe acute respiratory syndrome Coronavirus Spike protein symptomatic infection the receptor-binding domain the SARS-CoV-2 the vaccine Vaccine vaccine platform vaccine strain variant variants of concern virus [DOI] 10.1038/s41591-022-01877-1 PMC 바로가기 [Article Type] Article
Epigenetics may characterize asymptomatic COVID-19 infection후성 유전학은 무증상 COVID-19 감염을 특징지을 수 있습니다Article Published on 2022-07-272022-09-11 Journal: Human Genomics [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] Alter Analysis association Asymptomatic Asymptomatic COVID-19 Coronaviruses Course COVID-19 develop diagnosis of COVID-19 DNA methylation enveloped RNA viruses epigenetics had no Illumina Infection limitation Methylation methylation site no symptoms Patient PCR-based testing Peripheral blood peripheral blood samples positive Positive test RNA viruses RT-PCR SARS-CoV-2 Symptom symptomatic infection Symptoms tested with infection [DOI] 10.1186/s40246-022-00401-3 PMC 바로가기 [Article Type] Article
Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil브라질의 Omicron 기간에 CoronaVac + 이종 BNT162b2 부스터의 보호 기간Article Published on 2022-07-182022-09-11 Journal: Nature Communications [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] analysed BNT162b2 booster booster dose Brazil CoronaVac COVID-19 vaccine database death dominance dominant Duration Effectiveness evaluated Heterologous Hospitalization inactivated individual information offered omicron Omicron variant outcome outcomes symptomatic infection tested the SARS-CoV-2 the vaccine vaccinee vaccinees variant [DOI] 10.1038/s41467-022-31839-7 PMC 바로가기 [Article Type] Article
Symptoms and Glycemic Control in Young People With Type 1 Diabetes Following SARS-CoV-2 Infection: An Observational StudyObservational Study Published on 2022-07-142022-10-05 Journal: The Journal of Clinical Endocrinology and Metaboli [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI Adults age analyzed Asymptomatic asymptomatic infection children clinical manifestation clinical symptom clinics Cohort collected Comorbidity conducted Control Course COVID-19 COVID-19 infection Deterioration diabete diabetes Diabetic disease course DKA Effect elevated fatigue Fever Glucose glycemic control Headaches help Hospitalization identifying immunodeficiency Infection management measure median Mild occurred Odds ratio Older age outcomes Patient patients pediatric persistent polymerase chain positive prolonged disease Quantitative questionnaire regression analysis reported required SARS-CoV-2 SARS-COV-2 infection sense of smell sick Symptom symptomatic infection Symptoms syndrome T1D tested the disease Type Type 1 diabetes [DOI] 10.1210/clinem/dgac288 PMC 바로가기 [Article Type] Observational Study
COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in ScotlandDelta AY.4.2의 증상이 있는 SARS-CoV-2 감염 및 심각한 COVID-19 결과에 대한 COVID-19 백신 효과: 스코틀랜드의 540만 개인에 대한 코호트 및 테스트 음성 연구Article Published on 2022-07-092022-09-11 Journal: Journal of Global Health [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% CI 95% confidence interval accounted acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adults age BNT162b2 ChAdOx1 Chain Reaction cohort study Community conditions conducted confounders contributed coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 admission COVID-19 hospitalisation COVID-19 vaccine Cox proportional hazard Cox proportional hazards model death Delta Effectiveness enhanced Good hazard ratio Hospital admission increased risk individual individuals Infection Lineage mRNA mRNA-1273 mRNA-1273 vaccine mRNA-1273 vaccines offered omicron Omicron variant outcome performed platform polymerase chain polymerase chain reaction proportional hazards model provided reverse transcriptase Reverse transcriptase polymerase chain reaction RT-PCR SARS-CoV-2 SARS-COV-2 infection second vaccination security severe acute respiratory syndrome Coronavirus severe COVID-19 Sex socioeconomic status spline splines symptomatic symptomatic COVID-19 symptomatic infection symptomatic SARS-CoV-2 infection transcriptase United Kingdom vaccination Vaccine vaccine dose Vaccines variant variant of SARS-CoV-2 were infected [DOI] 10.7189/jogh.12.05025 PMC 바로가기 [Article Type] Article
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study캐나다 온타리오주 장기요양원에서 오미크론 변이에 대한 covid-19 mRNA 백신 4차 접종의 효과: 음성 설계 연구 테스트Article Published on 2022-07-062022-09-11 Journal: The BMJ [Category] COVID19(2023년), SARS, 변종, [키워드] 95% confidence interval BNT162b2 Canada Care Chain Reaction Characteristics Comorbidities Control death dominant dose doses Effectiveness Hospital admission Infection Logistic regression long term mRNA mRNA COVID-19 vaccines mRNA vaccine mRNA-1273 multivariable logistic regression Older Omicron variant outcome outcomes polymerase chain polymerase chain reaction positive recipient reverse transcription reverse transcription polymerase chain reaction RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 test Seven symptomatic symptomatic infection Test test negative test result tested the vaccine vaccination Vaccine vaccine dose was used [DOI] 10.1136/bmj-2022-071502 PMC 바로가기 [Article Type] Article
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design스코틀랜드의 증후성 질환에 대한 백신 부스터의 우려 및 효과에 대한 오미크론 변이의 심각도(EAVE II): 중첩 테스트 음성 디자인을 사용한 국가 코호트 연구Article Published on 2022-07-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted Admission booster booster dose Booster vaccine booster vaccines Care case-control study cohort analysis cohort study core COVID-19 defined Delta VOC dose dose of vaccination Edinburgh effective Effectiveness enhanced estimate Health Data Research UK Hospital admission hospitalisation individual individuals Infection initial Innovation laboratory data National offer omicron Omicron variant outcome platform positive positive RT-PCR proportion Public reduction in Reinfection risk risk of COVID-19 S-gene SARS-COV-2 infection Scottish severity Spread symptomatic symptomatic COVID-19 symptomatic disease symptomatic infection symptomatic SARS-CoV-2 infection tested the SARS-CoV-2 university vaccination Vaccine vaccine dose VoC with infection [DOI] 10.1016/S1473-3099(22)00141-4 PMC 바로가기 [Article Type] Article
Gamma variant vertically transmitted from a mild symptomatic pregnant woman associated with fatal neonatal COVIDCase report Published on 2022-07-012022-10-05 Journal: The Brazilian journal of infectious diseases : an [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] age coronavirus COVID COVID 19 death Gamma homology Hospital admission Infection Inflammatory knowledge Mild mother Neonatal Newborn P.1 polymerase chain Pregnancy Pregnant woman Preterm infant progressed real-time reverse transcriptase SARS-CoV-2 SARS-CoV-2 variant Sequencing severe respiratory disease symptomatic symptomatic infection syndrome Transmission transmitted variant vertical transmission [DOI] 10.1016/j.bjid.2022.102385 [Article Type] Case report